SCHEMBL1238697

SCHEMBL1238697

O=CCc1c(O)cccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.45
AKR1B1 P15121 1/20 0.44
ALDH1A1 P00352 3/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
TDP1 Q9NUW8 1/20 0.40
TAAR1 Q96RJ0 1/20 0.38
ADRA2A P08913 2/20 0.37
OPRK1 P41145 2/20 0.37
LMNA P02545 1/20 0.37
CYP3A4 P08684 1/20 0.37
HTR1A P08908 1/20 0.37
CYP2D6 P10635 1/20 0.37
CYP2C9 P11712 1/20 0.37
ADRA2B P18089 1/20 0.37
ADRA2C P18825 1/20 0.37
MAOA P21397 1/20 0.37
ADRA1D P25100 1/20 0.37
HTR2A P28223 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2727597 0.85 ERN1 (0.43) TSHRALDH1A1SMN1; SMN2TDP1LMNA
SCHEMBL168585 0.85 KMT2A (0.48) TSHRAKR1B1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL5274928 0.80 TSHR (0.45) TSHRAKR1B1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL5954018 0.76 TRPA1 (0.45) TSHRALDH1A1LMNAMAPK1HSD17B10
SCHEMBL5071067 0.76 AKR1B1 (0.44) TSHRAKR1B1ALDH1A1SMN1; SMN2KMT2A
SCHEMBL23507137 0.76 P2RX7 (0.40) AKR1B1ALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL3712558 0.76 MAOB (0.38) ALDH1A1SMN1; SMN2KMT2AMEN1TDP1
SCHEMBL21811819 0.76 CYP3A4 (0.37) TSHRALDH1A1SMN1; SMN2KMT2AMEN1
SCHEMBL29569478 0.76 TAAR1 (0.55) ALDH1A1SMN1; SMN2KMT2AMEN1TDP1
SCHEMBL1460113 0.76 TAAR1 (0.55) ALDH1A1SMN1; SMN2KMT2AMEN1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4041238-A1 ORAL COMPLEMENT FACTOR D INHIBITORS Biocryst Pharmaceuticals, Inc. (US) 2022-08-17 EP disclosed
WO-2021072198-A1 ORAL COMPLEMENT FACTOR D INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2021-04-15 WO disclosed
EP-2459568-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Frosst Canada Limited (CA) 2012-06-06 EP disclosed
EP-2398809-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Canada Inc. (CA) 2011-12-28 EP disclosed
WO-2011047481-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-04-28 WO disclosed
WO-2011011872-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-02-03 WO disclosed
WO-2010094120-A1 NOVEL SPIRO COMPOUNDS USEFUL AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-08-26 WO disclosed